ADRB2 and cancer: Several recent studies have reported beta adrenergic receptor (β-AR) expression across diverse tumor types [12-23], and a growing body of literature suggests a role for β-AR signaling in regulating multiple hallmarks of benign and malignant tumors [24-28].